Skip to main navigation Skip to search Skip to main content

CYP3A4*22 May Increase Bleeding Risk in Ticagrelor Users

  • VTT (former employee or external)
  • University of Eastern Finland
  • University of Helsinki
  • Helsinki University Hospital

Research output: Contribution to journalArticleScientificpeer-review

123 Downloads (Pure)
Original languageEnglish
Pages (from-to)202-207
JournalBasic and Clinical Pharmacology and Toxicology
Volume133
Issue number2
DOIs
Publication statusPublished - Aug 2023
MoE publication typeA1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adverse drug events
  • antiplatelet drugs
  • ischemic heart disease
  • pharmacogenetics
  • polymorphism
  • precision medicine

Cite this